Vaccines and medicines against COVID-19

Read about the current studies and development of vaccines and medicines for treatment of COVID-19, and how medicines can be approved much quicker in extraordinary situations, if patient safety is sufficiently assured.

Go to theme

DAC: The Data Analytics Centre of the Danish Medicines Agency

Read about DAC, the Data Analytics Centre of the Danish Medicines Agency. DAC will work to transform information and data on medicine and medicine devices into knowledge that can benefit the citizens.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2


Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.


EMA’s expert committee meets 6 January to decide on Moderna’s COVID-19 vaccine

22 December 2020

The expert committee of the European Medicines Agency, EMA, which is presently assessing Moderna’s application for conditional marketing authorisation of their COVID-19 vaccine in the EU has scheduled a meeting on 6 January at which it may recommend authorisation to the European Commission. If so, the European Commission may formally authorise the vaccine within a few days.

EMA starts rolling review of corona vaccine from Janssen

02 December 2020

EMA receives the first applications for conditional marketing authorisation of COVID-19 vaccines

02 December 2020

Remdesivir for treatment of COVID-19 to continue in Denmark and Europe until further notice

24 November 2020